We are live on ! Find out more
CANY

Caxton Associates (New York) Portfolio holdings

AUM $3.18B
1-Year Est. Return 54.49%
This Fund
S&P 500
This Quarter Est. Return
+13.69%
1 Year Est. Return
+54.49%
3 Year Est. Return
+73.91%
5 Year Est. Return
+212.89%
10 Year Est. Return
+632.2%
AUM
$729M
AUM Growth
+$226M
Cap. Flow
+$172M
Cap. Flow %
23.64%
Top 10 Hldgs %
50.98%
Holding
608
New
234
Increased
78
Reduced
67
Closed
221

Top Buys

Rank Stock Value
1
APTV icon
Aptiv
APTV
+$32.8M
2
BAC icon
Bank of America
BAC
+$10.9M
3
AMZN icon
Amazon
AMZN
+$8.85M
4
VOYA icon
Voya Financial
VOYA
+$8.52M
5
CFG icon
Citizens Financial Group
CFG
+$7.49M

Sector Composition

Rank Sector Weight
1 Financials 12.9%
2 Technology 12.09%
3 Consumer Discretionary 11.37%
4 Healthcare 5.03%
5 Industrials 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
151
AbbVie
ABBV
$435B
$571K 0.08%
+6,539
New +$543K
RWT
152
Redwood Trust
RWT
$594M
$570K 0.08%
+34,455
New +$566K
FAF icon
153
First American
FAF
$7.58B
$558K 0.08%
9,569
+4,276
+81% +$261K
CTAS icon
154
Cintas
CTAS
$81.3B
$556K 0.08%
+8,268
New +$544K
EVRI
155
DELISTED
Everi Holdings
EVRI
$556K 0.08%
+41,382
New +$472K
LAD icon
156
Lithia Motors
LAD
$8.26B
$553K 0.08%
3,760
+1,951
+108% +$293K
HAFC icon
157
Hanmi Financial
HAFC
$946M
$551K 0.08%
+27,579
New +$532K
LRCX icon
158
Lam Research
LRCX
$390B
$548K 0.08%
18,740
-46,650
-71% -$1.24M
MTH icon
159
Meritage Homes
MTH
$4.86B
$547K 0.08%
17,906
-4,910
-22% -$168K
FRO icon
160
Frontline
FRO
$8.85B
$546K 0.07%
42,490
+2,106
+5% +$22.9K
EW icon
161
Edwards Lifesciences
EW
$51.7B
$545K 0.07%
+7,008
New +$547K
FFG
162
DELISTED
FBL Financial Group
FFG
$540K 0.07%
9,159
CTSH icon
163
Cognizant
CTSH
$26B
$539K 0.07%
8,693
+4,112
+90% +$254K
THG icon
164
Hanover Insurance
THG
$7.98B
$538K 0.07%
3,935
-717
-15% -$96.5K
AVT icon
165
Avnet
AVT
$7.92B
$531K 0.07%
12,515
+4,327
+53% +$178K
IBP icon
166
Installed Building Products
IBP
$6.49B
$529K 0.07%
7,675
+4,113
+115% +$277K
ABR icon
167
Arbor Realty Trust
ABR
$998M
$528K 0.07%
+36,799
New +$523K
DRNA
168
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$528K 0.07%
+23,988
New +$483K
JBL icon
169
Jabil
JBL
$35.8B
$524K 0.07%
+12,679
New +$487K
AJG icon
170
Arthur J. Gallagher & Co
AJG
$63.6B
$523K 0.07%
+5,491
New +$503K
EXR icon
171
Extra Space Storage
EXR
$31.6B
$517K 0.07%
4,891
+720
+17% +$78.5K
SPNT icon
172
SiriusPoint
SPNT
$2.68B
$507K 0.07%
+48,179
New +$468K
MTZ icon
173
MasTec
MTZ
$21.9B
$498K 0.07%
7,758
+3,395
+78% +$224K
GPI icon
174
Group 1 Automotive
GPI
$3.18B
$496K 0.07%
4,964
-284
-5% -$28K
LEN icon
175
Lennar Class A
LEN
$21.2B
$493K 0.07%
+9,128
New +$521K

Similar funds

Caxton Associates (New York)'s Q4 2019 Portfolio in Review

As of Q4 2019, Caxton Associates (New York) held 608 positions worth $729M, up 45% from $503M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Caxton Associates (New York) deployed $172M of net new capital in Q4 2019, opening 234 new positions and adding to 78 existing holdings. Its largest new stake was Aptiv: 358,663 shares worth $34.1M.

By sector, the portfolio is most concentrated in Financials at 13% of assets, up from 9.2% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $53.8M trimmed.

  • Caxton Associates (New York)'s largest Q4 2019 buy was Aptiv: 358,663 shares worth $34.1M.
  • Caxton Associates (New York) added most to Bank of America in Q4 2019, an estimated $10.9M increase.
  • Caxton Associates (New York)'s biggest Q4 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $53.8M.
  • Caxton Associates (New York) fully exited Cheniere Energy in Q4 2019, selling an estimated $36.5M.
  • Caxton Associates (New York)'s ten largest holdings make up 51% of its $729M portfolio in Q4 2019.
  • Caxton Associates (New York) opened 234 new positions and closed 221 in Q4 2019.
  • Caxton Associates (New York)'s portfolio value rose 45% quarter-over-quarter to $729M.

Based on Caxton Associates (New York)'s 13F filing for Q4 2019, filed 14 Feb 2020.